A trio of myopia management visionaries has been honored with the prestigious British Contact Lens Association (BCLA) Industry Award for their work developing, researching and commercializing the innovative CooperVision® MiSight® 1 day contact lens. John Phillips, Stuart Cockerill and Paul Chamberlain were recognized at the BCLA Clinical Conference & Exhibition closing gala dinner, selected from a field of finalists who have all made immeasurable contributions to the field.

Myopia is projected to affect the vision and ocular health of approximately five billion people by 2050, more than doubling today’s numbers1. The rising prevalence of this condition, also known as nearsightedness or short-sightedness, is sparking the need to go beyond solely providing vision correction, to also deliver accessible, effective methods to slow the progression of myopia in children.

These factors led the three pioneers to each play a substantial role in developing and commercializing the MiSight® 1 day contact lens, which is now worn by more than 10,000 children around the world.

“Myopia management has been described as the ‘next contact lens revolution’—something more evident than ever at this year’s BCLA Conference. However, it takes inspiration, vision and dedication to integrate new technology into a commercially viable approach,” said James Gardner, Vice President, Global Myopia Management for CooperVision. “The foresight and years of effort from John, Stuart and Paul are well deserving of recognition from their peers and the industry. Yet they’ll be the first to tell you the honor is not about them—it’s about the thousands of children who are benefiting from that work every day. It’s this attitude that gives us hope that we can truly make an impact, working alongside ECPs to take on myopia.”

Click HERE for the full press release.